Glen Farr

Title: Glen Farr - Innovator in Antibody Production

Introduction

Glen Farr is a notable inventor based in Prospect, Connecticut, who has made significant contributions to the field of biotechnology. His work primarily focuses on methods for obtaining antibodies that bind to transmembrane proteins, which are crucial for various medical applications.

Latest Patents

Glen Farr holds a patent titled "Methods for obtaining antibodies that bind transmembrane proteins and cells that produce the same." This patent discloses innovative methods for obtaining cells that express antibodies targeting transmembrane proteins. It also details the generation of antibodies from these cells, as well as the nucleic acids encoding the antibodies. The methods utilize lipid bilayer-membrane scaffold protein complexes to present transmembrane protein antigens to cells, enhancing the efficiency of antibody production.

Career Highlights

Glen Farr is currently employed at Regeneron Pharmaceuticals, Inc., a leading biotechnology company known for its focus on developing innovative medicines. His work at Regeneron has allowed him to collaborate with other talented professionals in the field, further advancing the research and development of therapeutic antibodies.

Collaborations

Glen has worked alongside esteemed colleagues such as Gang Chen and Ergang Shi, contributing to a collaborative environment that fosters innovation and scientific discovery.

Conclusion

Glen Farr's contributions to antibody production and his innovative patent demonstrate his commitment to advancing biotechnology. His work continues to have a significant impact on the development of new therapeutic solutions.